{"id":"W1925809211","doi":"10.4081/aiua.2015.2.121","title":"Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"Archivio Italiano di Urologia e Andrologia","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cabazitaxel; Abiraterone acetate; Enzalutamide; Docetaxel; Prostate cancer; Internal medicine; Oncology; Hazard ratio; Adverse effect; Mitoxantrone; Placebo; Cancer; Pharmacology; Androgen deprivation therapy; Chemotherapy; Confidence interval; Androgen receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009612688,0.002207665,0.01766668,0.006432437,0.0004333286,0.002805732,0.00155302,0.001935465,0.003109147],"category_scores_gemma":[0.0211463,0.001281272,0.02646906,0.006157653,0.0005749514,0.001356098,0.0009209492,0.001436702,0.0003125068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002533241,"about_ca_system_score_gemma":0.003213721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005833058,"about_ca_topic_score_gemma":0.01331269,"domain_scores_codex":[0.9931923,0.00281964,0.002163413,0.0007256546,0.0009218702,0.0001771908],"domain_scores_gemma":[0.9864066,0.008981722,0.003086555,0.0002734145,0.001077929,0.0001736735],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0015296,0.00002727671,0.001353024,0.6351504,0.346516,0.00009468207,0.00005260883,0.0002977712,0.0002403804,0.00009517955,0.0004724017,0.01417061],"study_design_scores_gemma":[0.0008543923,0.0004919675,0.003200417,0.06366155,0.9284192,0.0001574259,0.00005077554,0.0001628825,0.0001626355,0.0001307485,0.002680735,0.00002736289],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002247552,0.9967253,0.0001831661,0.0000874623,0.00009436182,0.0002035919,0.0002828929,0.00001005767,0.0001657244],"genre_scores_gemma":[0.08132146,0.9153455,0.001179619,0.0005872787,0.0001690867,0.0006505119,0.0004899654,0.00001499012,0.0002416075],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01766668,"threshold_uncertainty_score":0.0508374,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1521952054855248,"score_gpt":0.4199884439919069,"score_spread":0.2677932385063821,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}